SCHEMBL8349130

SCHEMBL8349130

Cc1cnc(Nc2ccccc2)cc1-c1ccc(C(=O)NC2CCCCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 5/20 0.52
▸ ABL1 P00519 2/20 0.50
▸ RXFP1 Q9HBX9 2/20 0.49
▸ MAPT P10636 1/20 0.49
▸ HPGD P15428 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ CYP46A1 Q9Y6A2 1/20 0.47
▸ TTK P33981 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ JAK3 P52333 1/20 0.46
▸ TACR1 P25103 1/20 0.46
▸ GRM5 P41594 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8349797 0.82 PTPN1 (0.52) MAPK14ABL1ALDH1A1NPC1RAB9A
SCHEMBL8351193 0.81 MAPK10 (0.54) MAPK14RXFP1MAPTNPC1RAB9A
SCHEMBL14348413 0.80 CCNA2 (0.55) —
SCHEMBL8352845 0.79 GRM5 (0.65) MAPK14HPGDALDH1A1TSHRNPC1
SCHEMBL8351194 0.78 MAPK14 (0.55) MAPK14MAPTHPGDALDH1A1RAB9A
SCHEMBL8351537 0.76 RXFP1 (0.54) MAPK14RXFP1MAPTNPC1RAB9A
SCHEMBL5631456 0.74 MAPK14 (0.81) MAPK14HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL22308180 0.73 NPC1 (0.84) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL22289346 0.73 NPC1 (0.84) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL2983895 0.73 NPC1 (0.84) HPGDALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
WO-2004041789-A1 COMPOSITIONS USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-05-21 — — WO disclosed
Send feedback